The EU Commission conditionally clears the acquisition of a Belgian pharmaceuticals company by a US competitor (Abbott / Solvay Pharmaceuticals)

Gatti, John

Previous article The EU Commission conditionally clears a merger in the home-shopping sector (Otto / Primondo Assets) Next article The Danish Competition Authority revokes its decision to clear the merger between two agricultural companies (Danish Agro / Landbrugets Andel)

11 Feb 2010

The EU Commission conditionally clears the acquisition of a Belgian pharmaceuticals company by a US competitor (Abbott / Solvay Pharmaceuticals)

KEYWORDS

Reference

EU Commission, Abbott / Solvay Pharmaceuticals, Case COMP/M.5661, 11 February 2010

"Merger: main developments between 1 January and 30 April 2010" On 11 February the Commission approved the proposed acquisition of Solvay Pharma (Belgium) by Abbott Laboratories (USA). The decision is conditional upon the divestment of the Cystic Fibrosis testing business of Solvay Pharma’s

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

John Gatti
JG Associates (Brussels)

193 contributions 62500 visits

Quotation

John Gatti, The EU Commission conditionally clears the acquisition of a Belgian pharmaceuticals company by a US competitor (Abbott / Solvay Pharmaceuticals), 11 February 2010, e-Competitions February 2010, Art. N° 37500

Visites 386